X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (242153) 242153
Newspaper Article (4343) 4343
Magazine Article (1264) 1264
Book Chapter (1058) 1058
Personal Narrative (921) 921
Newsletter (768) 768
Patent (759) 759
Dissertation (492) 492
Book / eBook (340) 340
Book Review (173) 173
Web Resource (108) 108
Publication (103) 103
Transcript (89) 89
Special Collection (87) 87
Government Document (74) 74
Reference (73) 73
Trade Publication Article (73) 73
Report (62) 62
Conference Proceeding (59) 59
Streaming Video (11) 11
Paper (10) 10
Journal / eJournal (5) 5
Exam (4) 4
Archival Material (3) 3
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (158616) 158616
administration, oral (139854) 139854
male (109638) 109638
female (101841) 101841
animals (72215) 72215
adult (62226) 62226
middle aged (50371) 50371
pharmacology & pharmacy (35170) 35170
aged (33936) 33936
rats (32708) 32708
dentistry, oral surgery & medicine (22975) 22975
treatment outcome (22752) 22752
mice (22570) 22570
adolescent (21571) 21571
time factors (20884) 20884
dose-response relationship, drug (19209) 19209
dentistry (16758) 16758
child (15032) 15032
analysis (14218) 14218
pharmacokinetics (13744) 13744
double-blind method (12755) 12755
injections, intravenous (11946) 11946
research (11656) 11656
oncology (11450) 11450
drug administration schedule (11135) 11135
health aspects (11115) 11115
biological availability (10631) 10631
risk factors (10594) 10594
young adult (10562) 10562
care and treatment (10504) 10504
surgery (10128) 10128
therapy (9913) 9913
child, preschool (9806) 9806
immunology (9755) 9755
oral administration (9647) 9647
rats, sprague-dawley (9532) 9532
aged, 80 and over (9531) 9531
pregnancy (8947) 8947
cancer (8933) 8933
prospective studies (8911) 8911
follow-up studies (8658) 8658
children (8480) 8480
medicine, general & internal (8393) 8393
toxicology (8269) 8269
efficacy (8049) 8049
double-blind (7942) 7942
drug therapy (7930) 7930
rats, wistar (7769) 7769
medicine & public health (7757) 7757
metabolism (7618) 7618
infant (7611) 7611
prevention (7556) 7556
drug therapy, combination (7402) 7402
research article (7079) 7079
digestive, oral, and skin physiology (6981) 6981
retrospective studies (6977) 6977
management (6835) 6835
disease models, animal (6802) 6802
bioavailability (6545) 6545
endocrinology & metabolism (6436) 6436
pediatrics (6278) 6278
dosage and administration (6265) 6265
chemistry, medicinal (6229) 6229
drugs (6205) 6205
dogs (6179) 6179
medicine (6166) 6166
in-vitro (6112) 6112
clinical trials (6072) 6072
studies (6044) 6044
safety (6015) 6015
abridged index medicus (6009) 6009
oral contraceptives (5991) 5991
clinical trials as topic (5961) 5961
risk (5932) 5932
disease (5855) 5855
absorption (5829) 5829
expression (5691) 5691
area under curve (5551) 5551
cross-over studies (5530) 5530
inflammation (5518) 5518
half-life (5440) 5440
kinetics (5419) 5419
rodents (5271) 5271
biochemistry & molecular biology (5249) 5249
anticoagulants - administration & dosage (5243) 5243
patients (5209) 5209
medicine, research & experimental (5104) 5104
chemotherapy (5095) 5095
usage (4931) 4931
drug interactions (4883) 4883
pharmacology (4827) 4827
hematology (4784) 4784
internal medicine (4781) 4781
obstetrics & gynecology (4777) 4777
infusions, intravenous (4771) 4771
united states (4742) 4742
infectious diseases (4681) 4681
neurosciences (4627) 4627
physiological aspects (4598) 4598
public, environmental & occupational health (4589) 4589
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (68) 68
Online Resources - Online (60) 60
Gerstein Science - Stacks (52) 52
Dentistry (Harry R Abbott) - Stacks (45) 45
Collection Dvlpm't (Acquisitions) - Vendor file (24) 24
UTL at Downsview - May be requested (24) 24
OISE - Stacks (18) 18
UofT at Mississauga - Stacks (18) 18
UofT at Scarborough - Stacks (18) 18
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (12) 12
St. Michael's College (John M. Kelly) - 2nd Floor (9) 9
New College (Ivey) - Stacks (7) 7
Trinity College (John W Graham) - Stacks (7) 7
Faculty of Information - Stacks (4) 4
Law (Bora Laskin) - Stacks (4) 4
Pontifical Inst. Mediaeval Studies - Library use only (4) 4
Dentistry (Harry R Abbott) - Withdrawn (3) 3
Gerstein Science - Missing (3) 3
University College (Laidlaw) - Stacks (3) 3
Criminology - Stacks (2) 2
Media Commons - Microtexts (2) 2
Music - Stacks (2) 2
Robarts - Course Reserves (2) 2
Robarts - Government Pubs (2) 2
St. Augustine's Seminary - Stacks (2) 2
Victoria University CRRS - Library use only (2) 2
Aerospace - Stacks (1) 1
Business (Joseph L Rotman) - Stacks (1) 1
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Faculty of Information - May be requested in 6-10 wks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - May be requested in 6-10 wks (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Music - Circulation Desk (1) 1
Music - Protected Material (1) 1
OISE - Curriculum Resources (1) 1
OISE - Lost (1) 1
OISE - Reference (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Regis College - Stacks (1) 1
Robarts - Searching (1) 1
Robarts - Storage (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's College (John M. Kelly) - Internal dept (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (235244) 235244
Japanese (5537) 5537
German (5153) 5153
French (3276) 3276
Russian (1994) 1994
Spanish (1608) 1608
Italian (1151) 1151
Chinese (936) 936
Polish (741) 741
Portuguese (500) 500
Hungarian (252) 252
Danish (238) 238
Dutch (229) 229
Czech (223) 223
Swedish (192) 192
Bulgarian (181) 181
Norwegian (166) 166
Korean (129) 129
Ukrainian (82) 82
Turkish (81) 81
Finnish (68) 68
Hebrew (65) 65
Romanian (50) 50
Croatian (41) 41
Slovak (35) 35
Serbian (24) 24
Lithuanian (16) 16
Arabic (11) 11
Indonesian (6) 6
Persian (6) 6
Afrikaans (5) 5
Bosnian (4) 4
Greek (4) 4
Icelandic (3) 3
Slovenian (3) 3
Georgian (2) 2
Malay (1) 1
Thai (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical pharmacology and therapeutics, ISSN 1532-6535, 2014, Volume 96, Issue 3, pp. 349 - 359
.... It is therefore important to precisely and reliably evaluate their in vivo activity (phenotyping). A cocktail approach involving the administration of multiple CYP‐ or P‐gp... 
P4502B6 ACTIVITY | VORICONAZOLE | LC-MS/MS | SINGLE-POINT | ORAL MIDAZOLAM | VOLUNTEERS | IN-VIVO | PHARMACOLOGY & PHARMACY | DRUG-METABOLIZING-ENZYMES | KAROLINSKA COCKTAIL | BUPROPION HYDROXYLATION | Predictive Value of Tests | Pharmaceutical Preparations - blood | Caffeine - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Dried Blood Spot Testing | Humans | Omeprazole - blood | Bupropion - blood | Midazolam - administration & dosage | Substrate Specificity | Male | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Coffee | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Feasibility Studies | Enzyme Inhibitors - administration & dosage | Young Adult | Chromatography, Reverse-Phase | Tandem Mass Spectrometry | Capsules | Spectrometry, Mass, Electrospray Ionization | Flurbiprofen - administration & dosage | Adult | Dextromethorphan - pharmacokinetics | Terfenadine - blood | ATP-Binding Cassette, Sub-Family B, Member 1 - blood | Pharmaceutical Preparations - administration & dosage | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 Enzyme System - blood | Administration, Oral | Isoenzymes | Caffeine - blood | Omeprazole - administration & dosage | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Carbonated Beverages | Midazolam - pharmacokinetics | Bupropion - administration & dosage | Dextromethorphan - blood | Flurbiprofen - blood | Phenotype | Pilot Projects | Midazolam - blood | Dextromethorphan - administration & dosage | Usage | Glycoproteins | Liquid chromatography | Research | Pharmacokinetics | Cytochrome P-450 | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 08/2012, Volume 74, Issue 2, pp. 336 - 345
...). However, the potential for drug interactions with co‐administration of GSK2248761 and other antiretroviral medications or supportive medications is not known... 
NNRTI | HIV‐1 infection | antiretroviral therapy | drug‐drug interaction | HIV-1 infection | Drug-drug interaction | Antiretroviral therapy | PHARMACOKINETICS | TOLERABILITY | PHARMACOLOGY & PHARMACY | ATAZANAVIR | SIMVASTATIN | drug-drug interaction | PROTEASE INHIBITORS | Fluorobenzenes - pharmacokinetics | Pyrroles - pharmacokinetics | Darunavir | Ethinyl Estradiol - pharmacokinetics | Humans | Pyrrolidinones - pharmacokinetics | Male | Fluorobenzenes - administration & dosage | Indoles - administration & dosage | Lopinavir - pharmacokinetics | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | Tenofovir | Deoxycytidine - pharmacokinetics | Drug Interactions | Pyrroles - administration & dosage | Contraceptives, Oral - administration & dosage | Patient Safety | Atazanavir Sulfate | Contraceptives, Oral - pharmacokinetics | Phosphinic Acids - administration & dosage | Raltegravir Potassium | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Risk Assessment | Simvastatin - administration & dosage | Deoxycytidine - administration & dosage | Phosphinic Acids - pharmacokinetics | Rosuvastatin Calcium | Adenine - pharmacokinetics | Sulfonamides - pharmacokinetics | Cross-Over Studies | Cytochrome P-450 CYP3A - metabolism | Atorvastatin | Cytochrome P-450 CYP2D6 - metabolism | Least-Squares Analysis | Lopinavir - administration & dosage | Pyrimidines - pharmacokinetics | Oligopeptides - administration & dosage | Deoxycytidine - analogs & derivatives | Sulfonamides - administration & dosage | Cytochrome P-450 CYP2D6 Inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Heptanoic Acids - pharmacokinetics | Pyridines - pharmacokinetics | Reverse Transcriptase Inhibitors - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Reverse Transcriptase Inhibitors - pharmacokinetics | Heptanoic Acids - administration & dosage | Female | Ethinyl Estradiol - administration & dosage | Androstenes - pharmacokinetics | Double-Blind Method | Ritonavir - administration & dosage | Pyrimidines - administration & dosage | Oligopeptides - pharmacokinetics | Linear Models | Simvastatin - pharmacokinetics | Androstenes - administration & dosage | Adenine - administration & dosage | Organophosphonates - pharmacokinetics | Organophosphonates - administration & dosage | Cytochrome P-450 CYP3A Inhibitors | Ritonavir - pharmacokinetics | Anti-HIV Agents - pharmacokinetics | Indoles - pharmacokinetics | Drug Combinations | Urine | Simvastatin | Drug interactions | Cytochrome P-450 | HIV (Viruses) | Complications and side effects | Analysis | Electrocardiogram | Electrocardiography | DNA polymerases | Ethinyl estradiol | Dosage and administration | EKG | Antiviral agents | Urinalysis | Ritonavir | tenofovir | Cytochrome P450 | Lopinavir | ethinylestradiol | Blood | Infection | non-nucleoside reverse transcriptase inhibitors | Antiviral activity | Drug interaction | Probes | CYP2D6 protein
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2010, Volume 107, Issue 5, pp. 2159 - 2164
...). Administration of the probiotics mixture induced both T-cell and B-cell hyporesponsiveness and down-regulated T helper (Th... 
T lymphocytes | Probiotics | Inflammatory bowel diseases | Immune disorders | Population growth | Cytokines | Dendritic cells | B lymphocytes | Drug regulation | Mice | Inflammatory bowel disease | Inflammation | Atopic dermatitis | Rheumatoid arthritis | Regulatory T cell | MIGRATION | BACTERIA | MULTIDISCIPLINARY SCIENCES | RETINOIC-ACID | atopic dermatitis | regulatory T cell | INDUCTION | rheumatoid arthritis | FOXP3 | inflammatory bowel disease | EXPERIMENTAL ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | inflammation | ORAL TOLERANCE | MICE | EXPRESSION | Probiotics - administration & dosage | T-Lymphocytes, Regulatory - metabolism | Arthritis, Experimental - therapy | Dendritic Cells - immunology | Inflammatory Bowel Diseases - immunology | Dendritic Cells - pathology | Adoptive Transfer | Dermatitis, Atopic - therapy | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Arthritis, Experimental - pathology | CD11c Antigen - metabolism | Forkhead Transcription Factors - metabolism | Inflammatory Bowel Diseases - pathology | Dermatitis, Atopic - immunology | Immune System Diseases - pathology | Disease Models, Animal | Immune System Diseases - immunology | Mice, Transgenic | Arthritis, Experimental - immunology | Dermatitis, Atopic - pathology | Immunosuppression | Animals | Immune System Diseases - therapy | Mice, Inbred BALB C | Inflammatory Bowel Diseases - therapy | Biological Sciences
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 09/2017, Volume 2017, Issue 9, p. CD002309
Background Chronic obstructive pulmonary disease (COPD) is associated with cough, sputum production or dyspnoea and a reduction in lung function, quality of... 
Aminopyridines | Lungs & airways | Administration, Oral | Pulmonary Disease, Chronic Obstructive | Cyclopropanes | Disease Progression | Randomized Controlled Trials as Topic | Forced Expiratory Volume | Chronic obstructive pulmonary disease (stable) | Phosphodiesterase 4 Inhibitors | Quality of Life | Nitriles | Chronic obstructive pulmonary disease, stable ‐ pharmacotherapy | Cyclohexanecarboxylic Acids | Benzamides | Medicine General & Introductory Medical Sciences | Phosphodiesterases | Other medications | COST-EFFECTIVENESS ANALYSIS | Humans | LUNG-FUNCTION | Pulmonary Disease, Chronic Obstructive [drug therapy] | CORTICOSTEROID/LONG-ACTING BETA-AGONIST | MEDICINE, GENERAL & INTERNAL | Benzamides [administration & dosage; adverse effects] | Cyclopropanes [administration & dosage; adverse effects] | Aminopyridines [administration & dosage; adverse effects] | Forced Expiratory Volume [drug effects] | DOUBLE-BLIND | EXACERBATIONS | Phosphodiesterase 4 Inhibitors [administration & dosage; adverse effects] | PLACEBO-CONTROLLED TRIAL | QUALITY-OF-LIFE | Nitriles [administration & dosage; adverse effects] | COPD PATIENTS | LABA/LAMA/ICS TREATMENT | ROFLUMILAST | Cyclohexanecarboxylic Acids [administration & dosage; adverse effects] | Aminopyridines - administration & dosage | Forced Expiratory Volume - drug effects | Cyclohexanecarboxylic Acids - adverse effects | Aminopyridines - adverse effects | Cyclohexanecarboxylic Acids - administration & dosage | Cyclopropanes - adverse effects | Nitriles - administration & dosage | Benzamides - administration & dosage | Cyclopropanes - administration & dosage | Phosphodiesterase 4 Inhibitors - administration & dosage | Phosphodiesterase 4 Inhibitors - adverse effects | Nitriles - adverse effects | Benzamides - adverse effects | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2010, Volume 362, Issue 11, pp. 975 - 985
Journal Article
International Journal of Cardiology, ISSN 0167-5273, 2014, Volume 179, pp. 279 - 287
Journal Article